GIP-(10-30) [3673]
GIP-(10-30)
| SMILES | CCC(C)C(NC(=O)C(CO)NC(=O)C(N)Cc1ccc(O)cc1)C(=O)NC(C)C(=O)NC(CCSC)C(=O)NC(CC(=O)O)C(=O)NC(CCCCN)C(=O)NC(C(=O)NC(CCCN=C(N)N)C(=O)NC(CCC(N)=O)C(=O)NC(CCC(N)=O)C(=O)NC(CC(=O)O)C(=O)NC(Cc1ccccc1)C(=O)NC(C(=O)NC(CC(N)=O)C(=O)NC(Cc1c[nH]c2ccccc12)C(=O)NC(CC(C)C)C(=O)NC(CC(C)C)C(=O)NC(C)C(=O)NC(CCC(N)=O)C(=O)NC(CCCCN)C(=O)O)C(C)C)C(C)CC |
| InChIKey | VEGQOGPNPADXGF-UHFFFAOYSA-N |
| Sequence | YSIAMDKIRQQDFVNWLLAQK |
| HELM | PEPTIDE1{Y.S.I.A.M.D.K.I.R.Q.Q.D.F.V.N.W.L.L.A.Q.K}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | None |
| Hydrogen bond donors | None |
| Rotatable bonds | None |
| Log P | None |
| Molecular weight (Da) | None |
Database connections
|
|
No bioactivity data available.
GIP-(10-30)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Surrogate |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
|
|